Genomic analysis of prostate cancer stem cells isolated from a highly metastatic cell line

Cancer Genomics and Proteomics

Volumn 5, Issue 6, 2008, Pages 301-310

  Rowehl, Rebecca A ^a   Crawford, Howard ^a   Dufour, Antoine ^a   Ju, Jingfang ^a   Botchkina, Galina I ^a,b  

^a STONY BROOK UNIVERSITY   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

Cancer stem cells; DAVID analysis; Genome wide microarray; PC3MM2; Prostate cancer

Indexed keywords

ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; CD133 ANTIGEN; HERMES ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CANCER STEM CELL; CARCINOGENICITY; CELL EXPANSION; CELL ISOLATION; CONTROLLED STUDY; CULTURE TECHNIQUE; GENOME ANALYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PHENOTYPIC VARIATION; PROSTATE CANCER; SCID MOUSE; TUMOR SPHEROID;

MUS;

EID: 58249117794     PISSN: 11096535     EISSN: 17906245     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Wicha MS, Liu S and Dontu G: Cancer stem cells - a paradigm shift. Cancer Res 66: 1883-1890, 2006.
2. Dalerba P, Cho RW and Clarke MF: Cancer Stem Cells: Models and Concepts. Annual Rev Med 58: 267-284, 2007.
3. Mimeault M, Hauke R, Mehra PP and Batra SK: Recent advances in cancer stem/progenitor cell research: therapeutic implications for overcoming resistance to the most aggressive cancers. J Cell Mol Med 11: 981-1011, 2007.
4. Pardal R, Clarke MF and Morrison SJ: Applying the principles of stem cell biology to cancer. Nat Rev Cancer 3: 895-902, 2003.
5. Reya T and Clevers H: Wnt signaling in stem cells and cancer. Nature 434: 843-850, 2005.
6. Mimeault M and Batra SK: Recent advances on multiple tumorigenic cascades involved in prostatic cancer progression and targeting therapies. Carcinogenesis 27: 1-22, 2006.
7. Shmelkov SV, St. Clair R, Lyden D and Rafii S: AC133/CD133/Prominin-1. Int J Biochem Cell Biol 37: 715-719, 2005.
8. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J and Dirks PB: Identification of a cancer stem cell in human brain tumours. Cancer Research 63: 5821-5828, 2003.
9. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD and Dirks PB: Identification of human brain tumour initiating cells. Nature 432: 396-401, 2004.
10. + cancer stem cells in glioblastoma. Mol. Cancer 5: 67, 2006.
11. Bussolati B, Bruno S, Grange C, Buttiglieri S, Deregibus MC, Cantino D and Camussi G: Isolation of renal progenitor cells from adult human kidney. Am J Pathol 166: 545-555, 2005.
12. Collins AT, Barry PA, Hyde C, Stower MJ and Maitland NJ: Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 65: 10946-10951, 2005.
13. + hepatocellular carcinoma cells as cancer stem/progenitor cells. Biochem and Biophys Res Comm 351: 820-824, 2006.
14. Yin S, Li J, Hu C, Chwen X, Yao M and Yan M: CD133 positive hepatocellular carcinoma cells posess high capacity for tumorigenicity. Int J Cancer 120: 1444-1450, 2007.
15. O'Brien CA, Pollett A, Gallinger S and Dick J: A human colon cancer cell capable of initiating timor growth in immunodeficient mice. Nature 445: 106-110, 2007.
16. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C and De Maria R: Identification and expansion of human colon-cancer-initiating cells. Nature 445: 111-115, 2007.
17. Monzani E, Facchetti F, Galmozzi E, Corsini B, Benetti A, Cavazzin C, Gritti A, Piccinini A, Porro D, Santinami M, Invernici G, Parati E, Alessandri G and La Porta CA: Melanoma contains CD133 and ABCG2 positive cells with enhanced tumorigenic potential. Eur J Cancer 43: 935-946, 2007.
18. Eramo A, Lotti F, Sette G, Pilozzi E, Biffoni M, Di Virgilio A, Conticello C, Ruco L, Peschle C and Maria R: Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ 15: 504-514, 2008.
19. Hermann PC, Huber SL, Herrler T, Aicher A, Ellwart JW, Guba M, Bruns CJ and Heeschen C: Distinct Populations of Cancer Stem Cells Determine Tumor Growth and Metastatic Activity in Human Pancreatic Cancer. Cell Stem Cell 1: 313-323, 2007.
20. Florek M, Haase M, Marzesco AM, Freund D, Ehninger G and Huttner WB: Prominin-1/CD133, a neural and hematopoietic stem cell marker, is expressed in adult human differentiated cells and certain types of kidney cancer. Cell Tiss Res 319: 15-26, 2005.
21. Lardon J, Corbeil D, Huttner W, Ling Z and Bouwens L: Stem cell marker Prominin-1/AC133 is expressed in duct cells of the adult human p/ ancreas. Pancreas 36(1): e1-e6, 2008.
22. Shmelkov SV, Butler JM, Hooper AT, Hormigo A, Kushner J, Milde T, St Clair R, Baljevic M, White I, Jin DK, Chadburn A, Murphy AJ, Valenzuela DM, Gale NW, Thurston G, Yancopoulos GD, D'Angelica M, Kemeny N, Lyden D and Rafii S: CD133 expression is not restricted to stem cells, and both cd133+ and CD133- metastatic colon cancer cells initiate tumors. J Clinical Investigation 118(6): 2111-2120, 2008.
23. - glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res 67: 4010-4015, 2007.
24. Wang J, Saakariassen PO, Tsinkalovsky O, Immervoll H, Boe SO, Svendsen A, Prestegarden L, Rosland G, Thorsen F, Stuhr L, Molven A, Bjerkvig R and Enger PO: CD133 negative glioma cells form tumors in nude rats and give rise to CD 133 positive cells. Int J Cancer 122: 761-768, 2008.
25. Joo KM, Kim SY, Song SY, Kong DS, Lee JI, Jeon JW, Kim MH, Kang BG, Jing Y, Jin J, Hong SC, Park WY, Lee DS, Kim H and Nam DH: Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas. Lab Invest 6 (June 16), 2008.
26. Isaacs JT: Control of cell proliferation and cell death in the normal and neoplastic prostate: a stem cell model. In: Benign prostatic hyperplasia. Rodgers CH et al (eds.). Department of Health and Human Services. Bethesda, MD, pp. 85-94, 1985.
27. Hudson DL, O'Hare M, Watt FM and Masters JR: Proliferative heterogeneity in the human prostate: evidence for epithelial stem cells. Lab Invest 80: 1243-1250, 2000.
28. Collins AT, Habib FK, Maitland NJ and Neal DE: Identification and isolation of human prostate epithelial stem cells based on alpha(2)beta(1)-integrin expression. J Cell Sci 114: 3865-3872, 2001.
29. Richardson GD, Robson CN, Lang SH, Neal DE, Maintland NJ and Collins AT: CD133, a novel marker for human prostatic epithelial stem cells. J Cell Sci 117: 3539-3545, 2004.
30. Masters JR, Kane C, Yamamoto H and Ahmed A: Prostate cancer stem cell therapy: hype or hope? Prost Can & Prostatic Dis pp. 1-4, 2008.
31. Collins AT, Barry PA, Hyde C, Stower MJ and Maitland NJ: Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 65(23): 10946-10951, 2005.
32. + prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene 25: 1696-708, 2006.
33. Dean M, Fojo T and Bates S: Tumor stem cells and drug resistance. Nat Rev Cancer 5: 275-84, 2005.
34. Dingli D and Michor F: Successful therapy must eradicate cancer stem cells. Stem Cells 24: 2603-2610, 2006.
35. Frank NY, Pendse SS, Lapchak PH, Margaryan A, Shlain D, Doeing C, Sayegh MH and Frank MH: Regulation of progenitor cell fusion by ABCB5 P-glycoprotein, a novel human ATP-binding cassette transporter, J Biol Chem 278: 47156-47165, 2003.
36. Frank NY, Margaryan A, Huang Y, Schatton T, Waaga-Gasser AM, Gasser M, Sayegh MH, Sadee W and Frank MH: ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma. Cancer Res 65: 4320-4333, 2005.
37. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmelad AB, Dewhirst MW, Bigner DD and Rich JN: Glioma stem cells promote radioresistance by preferential activation of the DNA damage response, Nature 444: 756-760, 2006.
38. Hill RP, Chambers AF, Ling V and Harris JF: Dynamic heterogeneity: rapid generation of metastatic variants in mouse B16 melanoma cells. Science 224: 998-1001, 1984.
39. Hill RP: Identifying Cancer Stem Cells in Solid Tumors: Case Not Proven. Cancer Res 66: 1891-1896, 2006.
40. Watanabe T, Komuro Y, Kiyomatsu T, Kanazawa T, Kazama Y, Tanaka J, Tanaka T, Yamamoto Y, Shirane M, Muto M and Nagawa H: Prediction of sensitivity of rectal cancer cells in response to preoperative radioptherapy by DNA microarrray analysis of gene expression profiles. Cancer Res 66: 3370-3374, 2006.
41. Kang Y, Omura M, Suzuki A, Oka T, Nakagami Y, Cheng C, Nagashima Y and Inoue T: Development of an orthotopic transplantation model in nude mice that simulates the clinical features of human lung cancer. Cancer Sci 97: 996-1001, 2006.
42. Ponti D, Costa A, Zaffaroni N, Pratesi G, Petrangolini G, Coradini D, Pilotti S, Pierotti MA and Daidone MG: Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res 65: 5506-5511, 2005.
43. Dalerba P, Dylla SJ, Park IK, Liu R, Wang X, Cho RW, Hoey T, Gurney A, Huang EH, Simeone DM, Shelton AA, Parmiani G, Castelli C, and Clarke MF: Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci USA 104: 10158-10163, 2007.
44. Liu AY: Differential expression of cell surface molecules in prostate cancer cells. Cancer Res 60: 3429-3434, 2000.
45. Miki J, Furusato B, Li H, Gu y, Takahashi H, Egawa S, Sesterhenn IA, McLeod DG, Srivastava S and Rhim JS: Identification of putative stem cell markers, CD133 and CXCR4, in hTERT immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens. Cancer Res 67: 3153-3161, 2007.
46. Li H, Zhou J, Miki J, Furusato B, Gu Y, Srivastava S, McLeod DG, Vogel JC and Rhim JS: Telomerase-immortalized non-malignant human prostate epithelial cells retain the properties of multipotent stem cells. Exp Cell Res 314(1): 92-102, 2008.
47. Jin L, Hope KJ, Zhai Q, Smadja-Joffe and Dick JK: Targeting CD44 eradicates human acute myeloid leukemic stem cells. Nat. Med 12: 1167-1174, 2006.
48. Dontu G, Abdallah WM, Foley JM, Jackson KW, Clarke MF, Kawamura MJ and Wicha MS: In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev 17: 1253-1270, 2003.
49. Todaro M, Alea MP, Stefano AB, Cammareri P, Vermeulen L, Iovino F, Tripodo C, Russo A, Gulotta G, Medema JP and Stassi G: Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4. Cell Stem Cell 1: 389-402, 2007.
50. Hamilton G: Multicellular spheroids as an in vitro tumor model. Cancer Letters pp. 29-34, 1998.